Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure

NCT01587222 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped the sponsor did not provide the treatment

Conditions

Fibrosis
Renal Failure
Hepatorenal Syndrome

Interventions

DRUG: Albumin
DRUG: Midodrine
DRUG: Octreotide

Sponsor

Anna Cruceta